Ado-trastuzumab emtansine

靶点 ：her2

克隆性 ：多克隆

抗体英文名 ：Ado-trastuzumab emtansine

抗体名 ：曲妥珠单抗-美坦新偶联物

规格 ：5mg

Purchase
Description
Ado-trastuzumab emtansine is a HER2-targeted antibody-drug conjugate which contains the humanized anti-HER2 IgG1, trastuzumab, covalently linked to the microtubule inhibitory drug DM1 via the stable thioether linker MCC. Trastuzumab is produced by Chinese hamster ovary cells, and DM1-MCC are produced by chemical synthesis. Ado-trastuzumab emtansine contains an average of 3.5 DM1 molecules per antibody.
Ado-trastuzumab emtansine is supplied at a concentration of 20 mg/mL as a sterile, clear and colorless, preservative-free solution, which contains polysorbate 20 [0.02% (w/v)], sodium succinate (10 mM), and sucrose [6% (w/v)] with a pH of 5.0.
Properties

Name	Ado-trastuzumab emtansine
CAS NO.	1018448-65-1
Type	Whole antibody
Source	humanized (from mouse)
Target	HER2
Clone	Monoclone
Formula	C6448H9948N1720O2012S44
Molecular Weight	149 kDa
Antibody Form	Purified immunoglobulin
Physical Form	Solution
Grade Standard	Medicine Grade
Place of Origin	China (Mainland)
Storage	-70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.

Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
Detail information about the product please refer the website below:
 
 
https://en.wikipedia.org/wiki/Trastuzumab_emtansine